London-based VC firm Eka Ventures has closed its $107 million Fund II, bringing its total assets under management to $200 million.
- Eka Ventures invests in pre-seed and seed-stage companies, driving “positive system change” across three core areas: life, health, and sustainability.
- Its strategy targets consumer-led megatrends, backing founders building technologies that improve access to essential services, shift healthcare from reactive to preventative models, and accelerate decarbonisation across major consumer industries.
- According to Eka, Fund I ranks in the top 5% of its 2021 vintage for both DPI and TVPI. The portfolio includes companies such as Runna, Urban Jungle, Hived, Axle, Foresight Data Machines, Jude, and Flok Health, with 47% of investments sourced through its proprietary AI-driven sourcing platform designed to identify founders outside traditional venture networks.
- Fund II will continue this strategy, investing in up to 30 UK-based pre-seed and seed-stage startups, with typical initial cheques of around $2 million and significant reserves for follow-on funding.
- The firm will continue to lead or co-lead the majority of its deals, maintaining a hands-on investment approach while supporting founders over multiple stages of growth.
- Eka’s investor base for Fund II includes the British Business Bank, Better Society Capital, Guy’s & St Thomas’ Foundation, The Health Foundation, WRAP, Esmée Fairbairn Foundation, John Ellerman Foundation, and Vivensa Foundation, reflecting strong institutional and mission-aligned backing for its impact-focused investment thesis.
